A-A-0051732 (DM)
20 October 1986
INTERIM COMMERCIAL ITEM DESCRIPTION
NICLOSAMIDE TABLETS, CHEWABLE
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by DLA, Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient Characteristics:
Shall be a palatable, chewable, NiclosamideTablet.
Shall contain 500 mg of Niclosamide per tablet, within the applicable assay limits for the tablets.
Workmanship. The tablets shall be free from defects which may detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied 4 foil-wrapped tablets in a commercially available container. Ten such containers packaged together, as specified, constitute one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business